162 related articles for article (PubMed ID: 1583715)
1. Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
Garber GE
J Otolaryngol; 1992 Apr; 21(2):92-4. PubMed ID: 1583715
[TBL] [Abstract][Full Text] [Related]
2. Single-dose therapy for esophageal candidiasis with fluconazole.
Chave JP; Francioli P; Hirschel B; Glauser MP
AIDS; 1990 Oct; 4(10):1034-5. PubMed ID: 2261120
[No Abstract] [Full Text] [Related]
3. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
4. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
7. [Fluconazole--a new antifungal agent].
Dobloug JH
Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1961-3. PubMed ID: 1509458
[TBL] [Abstract][Full Text] [Related]
8. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole and fluconazole in oropharyngeal candidiasis.
van der Bijl P; Arendorf TM
Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
[TBL] [Abstract][Full Text] [Related]
10. Micafungin: a new echinocandin antifungal.
Joseph JM; Jain R; Danziger LH
Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
[TBL] [Abstract][Full Text] [Related]
12. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
[No Abstract] [Full Text] [Related]
13. [Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients].
Blancard A; Moulin-Traffort J; Regli P; Sarzier JM; Quilici M
Pathol Biol (Paris); 1991 May; 39(5):534-8. PubMed ID: 1881690
[TBL] [Abstract][Full Text] [Related]
14. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
Sow PS; Diop BM; Ndiaye I; Faye MA; Coll-Seck AM
Dakar Med; 1993; 38(1):85-8. PubMed ID: 7882856
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole prophylaxis in HIV disease, revisited.
Bozzette SA
Clin Infect Dis; 2005 Nov; 41(10):1481-2. PubMed ID: 16231261
[No Abstract] [Full Text] [Related]
16. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Fortun Abete J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
[No Abstract] [Full Text] [Related]
17. Fluconazole found effective against candidiasis.
Oncology (Williston Park); 1989 Nov; 3(11):112. PubMed ID: 2561879
[No Abstract] [Full Text] [Related]
18. Fluconazole: a new antifungal agent.
Kowalsky SF; Dixon DM
Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
[TBL] [Abstract][Full Text] [Related]
19. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
[TBL] [Abstract][Full Text] [Related]
20. Rationalizing prescribing for oral and oesophageal candidiasis.
Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
[No Abstract] [Full Text] [Related]
[Next] [New Search]